These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25559266)

  • 21. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
    Musgrave BL; Watson CL; Hoskin DW
    J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
    Smith DJ; McGuire MJ; Tocci MJ; Thiele DL
    J Immunol; 1997 Jan; 158(1):163-70. PubMed ID: 8977187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
    Stalder T; Hahn S; Erb P
    J Immunol; 1994 Feb; 152(3):1127-33. PubMed ID: 7507960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic regulation of permissive histone modifications and GATA3 binding underpin acquisition of granzyme A expression by virus-specific CD8(+) T cells.
    Nguyen ML; Hatton L; Li J; Olshansky M; Kelso A; Russ BE; Turner SJ
    Eur J Immunol; 2016 Feb; 46(2):307-18. PubMed ID: 26519105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic T lymphocyte clones that proliferate autonomously to specific alloantigenic stimulation. II. Relationship of the Lyt-2 molecular complex to cytolytic activity, proliferation, and lymphokine secretion.
    Glasebrook AL; Kelso A; MacDonald HR
    J Immunol; 1983 Apr; 130(4):1545-51. PubMed ID: 6187814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
    Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
    J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
    Gullo CA; Esser MT; Fuller CL; Lam Braciale V
    J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2.
    Schröter M; Lowin B; Borner C; Tschopp J
    Eur J Immunol; 1995 Dec; 25(12):3509-13. PubMed ID: 8566045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
    Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
    J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis.
    Pardo J; Bosque A; Brehm R; Wallich R; Naval J; Müllbacher A; Anel A; Simon MM
    J Cell Biol; 2004 Nov; 167(3):457-68. PubMed ID: 15534000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation requirements for antigen- and mitogen-induced interferon-gamma release from cytotoxic T lymphocytes.
    Klein JR; Pasternack MS; Bevan MJ
    J Immunol; 1985 Apr; 134(4):2456-61. PubMed ID: 3156183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo analysis of adenovirus-specific cytotoxic T lymphocyte response in mice deficient in CD28, fas ligand, and perforin.
    Chen J; Hsu HC; Zajac AJ; Wu Q; Yang P; Xu X; McPherson SA; Li J; Curiel DT; Mountz JD
    Hum Gene Ther; 2006 Jun; 17(6):669-82. PubMed ID: 16776575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
    Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
    J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.